Skip to content

Terms of Use

Content is informational. Affiliate links may earn commission. Tirzepatidepills is not affiliated with any vendor unless explicitly stated.

Reviewed by the Tirzepatidepills Research Team · Last updated March 2026

References & Scientific Sources

  1. Ludvik B, et al. Tirzepatide versus insulin degludec (SURPASS-3). Lancet. 2021.
  2. Del Prato S, et al. Tirzepatide versus insulin glargine (SURPASS-4). Lancet. 2021.
  3. Coskun T, et al. Tirzepatide, a dual GIP/GLP-1 receptor agonist: mechanism. Mol Metab. 2018.

Sources are provided for educational reference. This content is informational and not a substitute for professional medical advice.